MAPT and Alzheimer disease: Other SAMP8 AD characteristics include hyperphosphorylation of Tau [42], oxidative damage [43], decreased choline acetyl transferase activity [44], increased glutamate [45], altered NMDA receptor function [46] and increased neuronal nitric oxide synthase [47].